Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
21 - 30 out of 37Page size: 10
  1. 2021
  2. Published

    The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial

    Heimbürger, S. M. N., Hoe, B., Nielsen, C. N., Bergmann, N. C., Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina, Dejgaard, T. F., Christensen, Mikkel Bring & Knop, Filip Krag, 2021, In: Diabetologia. 64, p. 2425-2431

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance

    Jain, A. B., Ali, A., Gorgojo Martínez, J. J., Hramiak, I., Kavia, K., Madsbad, Sten, Potier, L., Prohaska, B. D., Strong, J. L. & Vilsbøll, Tina, 1 Feb 2021, In: International Journal of Clinical Practice. 75, 2, 14 p., e13731.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring

    Juel, C. T. B., Dejgaard, T. F., Hansen, C. P., Storkholm, J. H., Vilsbøll, Tina, Lund, A. & Knop, Filip Krag, 2021, In: The Journal of clinical endocrinology and metabolism. 106, 1, p. 168-173 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Response to letter to the editor from McKee and McGill: “Glycemic control and variability of diabetes secondary to total pancreatectomy assessed by continuous glucose monitoring”

    Juel, C. T. B., Dejgaard, T. F., Hansen, C. P., Storkholm, J. H., Vilsbøll, Tina, Lund, A. & Knop, Filip Krag, 2021, In: Journal of Clinical Endocrinology and Metabolism. 106, 10, p. E4307-E4308

    Research output: Contribution to journal › Comment/debate › Research

  6. Published

    Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes

    Kim, A., Knudsen, J. G., Madara, J. C., Benrick, A., Hill, T. G., Kadir, L. A., Kellard, J. A., Mellander, L., Miranda, C., Lin, H., James, T., Suba, K., Spigelman, A. F., Wu, Y., Macdonald, P. E., Asterholm, I. W., Magnussen, T., Christensen, M., Vilsbøll, T., Salem, V. & 4 others, Knop, Filip Krag, Rorsman, P., Lowell, B. B. & Briant, L. J. B., 2021, In: eLife. 10, 29 p., e72919.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption

    Kårhus, M. L., Brønden, A., Forman, Julie Lyng, Haaber, A., Vilsbøll, Tina, Sonne, D. P. & Knop, Filip Krag, 2021, In: BMJ Open. 11, 2, e044711.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  8. Published

    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes – randomized controlled trial

    Maagensen, H., Larsen, J. R., Jørgensen, Niklas Rye, Fink-Jensen, Anders & Vilsbøll, Tina, 2021, In: Psychiatry Research. 296, 113670.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis

    Mann, J. F. E., Buse, J. B., Idorn, T., Leiter, L. A., Pratley, R. E., Rasmussen, S., Vilsbøll, Tina, Wolthers, B. & Perkovic, V., 2021, In: Diabetes, Obesity and Metabolism. 23, 9, p. 2058-2066 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

    Mathiesen, D. S., Lund, A., Vilsbøll, Tina, Knop, Filip Krag & Bagger, J. I., 2021, In: Frontiers in Endocrinology. 11, 617400.

    Research output: Contribution to journal › Review › Research › peer-review

  11. Published

    The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

    Nerild, H. H., Brønden, Andreas, Haddouchi, A. E., Holst, Jens Juul, Sonne, D. P., Vilsbøll, Tina & Knop, Filip Krag, 2021, In: Diabetologia. 64, SUPPL 1, p. 217-217 422.

    Research output: Contribution to journal › Conference abstract in journal › Research

Previous 1 2 3 4 Next

ID: 33056950